In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 21, 2017
has subject area
- 11 Medical and Health Sciences (FoR)
- Antipsychotic Agents (MeSH)
- Delirium (MeSH)
- Double-Blind Method (MeSH)
- General & Internal Medicine (Science Metrix)
- Haloperidol (MeSH)
- Humans (MeSH)
- Palliative Care (MeSH)
- Risperidone (MeSH)
published in
- Annals of Internal Medicine Journal